About KEVEYIS
Gain greater control over Primary Periodic Paralysis with KEVEYIS®
KEVEYIS is proven to treat PPP1-3
KEVEYIS is a daily pill proven to reduce the number, severity, and length of PPP episodes in 2 clinical studies.1-3 It’s the first drug approved by the FDA for treatment of PPP.1
In a clinical study, people taking KEVEYIS reported1,2:
-
Number of episodes decreased
People taking KEVEYIS had fewer weekly episodes. -
Episodes were not as severe
Patients taking KEVEYIS reported that their episodes were not as severe. -
Episodes were shorter
When patients taking KEVEYIS did have episodes, they didn’t last as long.
Taking KEVEYIS
KEVEYIS is a pill that you take by mouth once or twice a day, depending on what your doctor prescribed.1 Treatment with KEVEYIS is personalized, so your doctor can change your dose to find what’s right for you.
Before you start KEVEYIS, work with your doctor to set treatment goals to track your progress while on KEVEYIS.1
KEVEYIS common side effects1
It’s normal to experience certain side effects when you start taking KEVEYIS. Some side effects can be managed with the help of your doctor. Consult your doctor if you have any questions about or experience side effects while taking KEVEYIS.
Tingling or prickling sensations
(pins and needles)
Confusion or trouble paying attention
Changes in taste
Brain fog
PATIENT TESTIMONIALS
Real KEVEYIS stories
Paul
KEVEYIS patient
Kirsten
KEVEYIS patient
Dennis
KEVEYIS patient
Janine
KEVEYIS patient
Take the next step
Get customized support for your KEVEYIS journey. Simply fill out the information, and a Patient Access Manager will contact you. They will walk you through the entire process, from diagnosis to treatment and beyond.
By submitting this form, I understand I am giving Xeris Pharmaceuticals, Inc., its affiliates, and business partners permission to use the personal information provided in this registration form to contact me by the following methods, but not limited to: mail, email, telephone call or in-person about disease and product information, disease or product-related events, support services, market research, and to share promotional and marketing information. By submitting this form, I consent to these uses and am confirming that I have read and agree to the Xeris Pharmaceuticals® Terms of Use and Privacy Statement. I understand I can unsubscribe by clicking on the unsubscribe link in future communications or by sending a letter with my full contact information (eg, name, address, email, phone, etc) to Xeris CareConnection™ Patient Support Services, 1375 W Fulton Street, Suite 1300, Chicago, IL 60607.
References
- KEVEYIS [package insert]. Chicago, IL; Xeris Pharmaceuticals, Inc.
- Sansone VA, Burge J, McDermott MP, et al; for the Muscle Study Group. Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis. Neurology. 2016;86:1408-1416.
- Tawil R, McDermott MP, Brown R, et al. Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis. Ann Neurol. 2000;47(1):46-53.
